Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have gained traction for the management of type 2 diabetes and obesity. Unlike several classes of antidiabetic medications that contribute to weight gain, GLP-1RAs not only reduce haemoglobin A1c, but also promote weight loss. While there is a lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Berman, Casey, Vidmar, Alaina P, Chao, Lily C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2023
Materias:
Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258616/
https://www.ncbi.nlm.nih.gov/pubmed/37313232
http://dx.doi.org/10.17925/EE.2023.19.1.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258616/
https://www.ncbi.nlm.nih.gov/pubmed/37313232
http://dx.doi.org/10.17925/EE.2023.19.1.38

Ejemplares similares